Simcere Pharmaceutical said on Monday its unit had granted U.S. drugmaker AbbVie the option to license its new blood cancer ...

The number of layoffs in the U.S. pharmaceutical industry exceeded 14,000 last year, a 9% increase from 2023 ...

The biopharma industry’s deal-a-palooza, better known as the J.P. Morgan Healthcare Conference, has kicked off in San ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...

As global markets navigate the complexities of a resilient U.S. labor market and persistent inflation concerns, investors are witnessing choppy conditions with significant fluctuations in major ...

Chinese health authorities said on Thursday they had detected the new mutated mpox strain clade Ib as the viral infection ...

Anti-corruption campaign brings down senior health officials, hospital directors, academics, and pharmaceutical company ...

The Chinese foreign ministry said on Friday that it had maintained close communication with the World Health Organization ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Astellas Pharma Inc. announced that China’s National Medical Products Administration (NMPA) has approved Padcev (enfortumab vedotin) in combination with Keytruda (pembrolizumab) for adult patients ...

President-elect Trump’s plan to enact heavy tariffs on certain imports could affect the prices and availability of ...